Guidelines

These Guidelines, prepared and reviewed by leading experts and based on the findings of evidence-based medicine, provide you with a set of recommendations to help patients with the best care options and to go forward in research of Neurogastroenterology and Motility.

2021

UEG and ESNM consensus on functional dyspepsia

Brief description of the initiative: Functional dyspepsia (FD) is one of the most common conditions in clinical practice. In spite of its prevalence, FD is associated with major uncertainties in terms of its definition, underlying pathophysiology, diagnosis, treatment, and prognosis. A Delphi consensus was initiated with 41 experts from 22 European countries who conducted a literature summary and voting process on 87 statements. Quality of evidence was evaluated using the grading of recommendations, assessment, development, and evaluation (GRADE) criteria. Consensus (defined as >80% agreement) was reached for 36 statements.

These guidelines were developed with the support of a UEG Activity Grant.
This article is published simultaneously in United European Gastroenterology Journal and Neurogastroenterology and Mobility.

Support/Lead: Support
Main author: Wauters, L., Dickman, R., Drug, V., Mulak, A., Serra, J., Enck, P., Tack, J., , Accarino, A., Barbara, G., Bor, S., Coffin, B., Corsetti, M., De Schepper, H., Dumitrascu, D., Farmer, A., Gourcerol, G., Hauser, G., Hausken, T., Karamanolis, G., Keszthelyi, D., Malagelada, C., Milosavljevic, T., Muris, J., O’Morain, C., Papathanasopoulos, A., Pohl, D., Rumyantseva, D., Sarnelli, G., Savarino, E., Schol, J., Sheptulin, A., Smet, A., Stengel, A., Storonova, O., Storr, M., Törnblom, H., Vanuytsel, T., Velosa, M., Waluga, M., Zarate, N. and Zerbib, F. (2021)

Comments: published 29. September 2021

Joint European Clinical Practice Guideline for Fecal Incontinence – a UEG/ESCP/ESNM/ESPCG guideline

Brief description of the initiative: The guidelines will provide guidance on the most effective treatment and management of patients with FI. By providing this information, we specifically aim to improve treatment outcomes and patient satisfaction. The development of the guideline will be based on internationally recognized guideline development methodology. These include criteria of quality, as detailed in the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument, primary methodological research and evaluation undertaken by the guideline development group (GDG).

Support/Lead: Support
Main author: Daniel Keszthelyi
Comments: finalised first half 2021

Breath testing in digestive diseases – EAGEN/ESNM/ESPGHAN/Hungarian Society/Romanian Society/ Bulgarian Society

Brief description of the initiative: A guideline will be developed to define the clinical indications, performance and rational interpretation of breath tests (H2, CH4 and 13C-breath tests) in adult and paediatric patients. The topic of the guideline will address, in large part functional bloating and diarrhoea. Specifically, it will provide recommendations for the use of breath tests in the evaluation of patients with these symptoms, which are a very common reason for attendance in gastroenterological and in general medical practices.

Support/Lead: Support

Main author: Heinz Hammer, Jutta Keller

Comments: 2 guidelines, close to beeing finalised

Functional Dyspepsia and Gastroparesis

Brief description of the initiative: The guidelines will provide guidance on the most effective treatment and management of patients with FI. By providing this information, we specifically aim to improve treatment outcomes and patient satisfaction. The development of the guideline will be based on internationally recognized guideline development methodology. These include criteria of quality, as detailed in the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument, primary methodological research and evaluation undertaken by the guideline development group (GDG).

Support/Lead: Lead

Main author: Paul Enck, Jan Tack

Comments: 2 guidelines in press

Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0

Chicago Classification v4.0 (CCv4.0) is the updated classification scheme for esophageal motility disorders using metrics from high-resolution manometry (HRM). Fifty-two diverse international experts separated into seven working subgroups utilized formal validated methodologies over two-years to develop CCv4.0.

Support/Lead: Support
Main author:
Comments:

2020

European guidelines on achalasia - UEG and ESNM recommendations

Achalasia is a primary motor disorder of the oesophagus characterised by absence of peristalsis and insufficient lower oesophageal sphincter relaxation. With new advances and developments in achalasia management, there is an increasing demand for comprehensive evidence-based guidelines to assist clinicians in achalasia patient care.

Authors: RAB Oude Nijhuis, G Zaninotto, S Roman, GE Boeckxstaens, P Fockens, MW Langendam, AA Plumb, AJPM Smout, EM Targarona, AS Trukhmanov, BLAM Weusten, and AJ Bredenoord

Comments: First Published February 5, 2020

ESNM Guidelines on functional constipation in adults: Further reflections and considerations

These guidelines clear up some common statements and believes on a widespread clinical condition such as functional constipation in adult patients.

Main Authors: L Brusciano, G Gualtieri, C Gambardella

Comments: First published June 9, 2020

2019

ESNM Guidelines on functional constipation in adults

Chronic constipation is a common disorder with a reported prevalence ranging from 3% to 27% in the general population. Several management strategies, including diagnostic tests, empiric treatments, and specific treatments, have been developed.

Main Authors: Jordi Serra, Daniel Pohl, Fernando Azpiroz, Giuseppe Chiarioni

Comments: First published November 22, 2019

2015

ANMS‐ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders

Anorectal disorders such as dyssynergic defecation, fecal incontinence, levator ani syndrome, and solitary rectal ulcer syndrome are common, and affect both the adult and pediatric populations. Although they are treated with several treatment approaches, over the last two decades, biofeedback therapy using visual and verbal feedback techniques has emerged as an useful option. Because it is safe, it is commonly recommended. However, the clinical efficacy of biofeedback therapy in adults and children is not clearly known, and there is a lack of critical appraisal of the techniques used and the outcomes of biofeedback therapy for these disorders.

Main Authors: S. S. C. Rao,  M. A. Benninga, A. E. Bharucha, G. Chiarioni, C. Di Lorenzo, W. E. Whitehead

Comments: First published April 01, 2015

Copyright 2021